Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma

Targeted therapies have drastically changed the management of metastatic melanoma and have shown encouraging results on tumour progression but are also known for their high rates of adverse reactions. In general, targeted therapies are contraindicated during pregnancy due to concerns about teratogen...

Descripción completa

Detalles Bibliográficos
Autores principales: de Haan, Jorine, van Thienen, Johannes V., Casaer, Michael, Hannivoort, Rebekka A., Van Calsteren, Kristel, van Tuyl, Minke, van Gerwen, Mathilde M., Debeer, Anne, Amant, Frédéric, Painter, Rebecca C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869570/
https://www.ncbi.nlm.nih.gov/pubmed/29606950
http://dx.doi.org/10.1159/000487128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869570/
https://www.ncbi.nlm.nih.gov/pubmed/29606950
http://dx.doi.org/10.1159/000487128

Ejemplares similares